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Summary: A study of the ovary as a s i te  of  action of arginine vasotocin, 
a nonapeptide synthesized in the pineal gland of vertebrates, was conducted 
in the rat .  Progesterone production stimulated by e i ther  human Chorionic 
Gonadotropin or 8Br-cycl ic Adenosine 3 ' ,5 '  Monophosphate was s ign i f i can t l y  
reduced in rats pretreated with arginine vasotocin. The a f f i n i t y  and receptor 
number for human chorionic gonadotropin were uneffected by pretreatment with 
arginine vasotocin. These resul ts suggest that  the antigonadotropic action 
a t t r ibu ted  to arginine vasotocin may be due to an inh ib i t i on  of ovarian 
steroidogenesis at a point d ista l  to cyc l ic  Adenosine 3 ' ,5 '  Monophosphate 
formation. 
INTRODUCTION 
Arginine vasotocin (AVT) is a nonapeptide synthesized and stored in the 
pineal gland of Vertebrates ( I -3 ) .  Previous studies have established that 
AVT possesses antigonadotropic actions such as acting as an abor t i fac ien t  (4), 
blocking ovulat ion (5),  and causing a reduction in sex organ weight (6). The 
s i te  and the mechanism of i nh ib i t i on  of the hypothalamo-hypophyseal-gonadal 
axis by AVT have not been defined, however (7). The present study inves t i -  
gated the e f fec t  of  AVT on the ovary as a possible s i te  of i t s  antigonado- 
t rop ic  act ions. 
MATERIALS AND METHODS 
Female 24 to 26 day old Sprague-Dawley rats were used in the present 
studies. The rats were made pseudopregnant by subcutaneous in jec t ion  with 
g= 
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50 IU pregnant mare's serum gonadotropin followed 56 h l a te r  by 25 IU hCG as 
described by Parlow (8). Six days a f te r  the hCG in jec t ions the rats received 
three subcutaneous in jec t ions of  e i ther  0.9% NaCl or AVT (4 ~g dissolved in 
I00 ml sa l ine) .  Twenty-four hours fol lowing the in jec t ions ,  the rats were 
then k i l l e d  and a collagenase dispersed luteal cel l  suspension was prepared 
as described ea r l i e r  (9). Approximately IxlO ~ luteal ce l ls  (0.I ml) were 
incubated in tubes containing 0.3 ml Medium 199 in the presence or absence of 
hCG or 8Br-cAMP. The incubation was carr ied out for three hours in a 
metabolic shaking incubator at 37°C in the presence of 95% oxygen and 5% 
carbon dioxide. At the end of the incubation, the reaction was stopped by 
placing the tubes in a boi l ing water bath for  three minutes. To the samples. 
0.6 ml o f  water and I0 ul of  [3H]-progesterone (approx. I0,000 cpm) were 
added to monitor recovery. The tubes were stored at 4°C overnight and the 
samples were extracted with petroleum ether and assayed for progesterone by 
radioimmunoassay ( I0) .  
A second group of s im i la r l y  in jected rats were k i l l ed  and the speci f ic  
binding of  [1251]-hCG to p a r t i a l l y  pur i f ied  luteal  cel l  plasma membranes was 
determined by the method described ea r l i e r  from th is  laboratory ( I I ) .  
Al iquots of pur i f ied  membrane were incubated for 90 minutes at 37°C in 0.3 ml 
0.25 M sucrose containing I0 mM Tris HCI (pH 7.5) in the presence of  varying 
concentrations of [12S]~hCG (45,000 cpm/ng). At each concentration of [12Sl]- 
hCG the ce l ls  were incubated with and without unlabeled hCG (I0 Ug) to 
determine spec i f ic  binding. The binding reaction was stopped by adding 1 ml 
of 0.25 M sucrose Tris HCI followed by cent r i fugat ion at I0,000 rpm for  
I0 min in a Sorvall re f r igera ted centr i fuge f i t t e d  with a SS34 rotor .  The 
pe l le t  was washed once with 1 ml of  fresh 0.25 M sucrose. The sedimented 
membrane was counted for bound rad ioac t i v i t y  in a gamma counter (Searle 
Analyt ic Mark I ) .  The spec i f ic  binding was determined by subtract ing the 
nonspecif ic binding from the tota l  binding. DNA was estimated by the co lo r i -  
metric method of  Burton (12). 
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Fig. I .  Effect of increasing concentrations of hCG on steroidogenesis by 
luteal cel ls in the presence or absence of pretreatment with AVT. 
Rats were pretreated with saline or AVT. Luteal cells were incu- 
bated with the indicated concentrations of hCG for 3 hours in an 
atmosphere of 95% oxygen and 5% carbon dioxide. The samples were 
processed for progesterone assay as described in Materials and 
Methods. Results are expressed as the mean of t r i p l i ca te  samples 
on duplicate determinations. 
Fig. 2. Effect of increasing concentrations of 8Br-cAMP on Steroidogenesis 
by luteal cel ls in the presence or absence of preinjection of AVT. 
Incubation conditions were similar to Figure 1 except the indicated 
concentrations of 8Br-cAMP were added. 
RESULTS AND DISCUSSION 
Effect  o f  AVT on hCG-stimulated steroidogenesis by ra t  l u t e a l  c e l l s .  Figure 1 
shows tha t  increas ing concentrat ions o f  hCG st imulated progesterone product ion 
in a dose re la ted  manner resu l t i ng  in a 4 - fo ld  s t imu la t i on .  At a l l  concentra- 
t ions o f  hCG, pretreatment wi th AVT produced a 50% reduct ion o f  gonadotropin- 
induced s tero idogenesis .  The reduct ion was s i g n i f i c a n t  (Student 's T - t es t ,  
p < 0.01) a t  concentrat ions o f  hCG greater  than 0.I ng/ml. 
Ef fect  o f  AVT on 8Bromo-cyclic AMP-stimulated stero idogenesis by ra t  l u t e a l  
c e l l s .  Figure 2 demDstrates that  increas ing concentrat ions o f  8Br-cAMP 
st imulated progesterone product ion in a dose re la ted  manner from 0,01 to 
1.0 mM concentrat ions.  Pretreatment wi th  AVT i n h i b i t e d  stero idogenesis at a l l  
concentrat ions o f  8Br-cAMP, and was s~gn i f i can t  (p < 0.01) at concentrat ions 
o f  8Br-cAMP greater  than 0.I  mM. 
Ef fect  o f  AVT on [12Sl]-hCG binding to p u r i f i e d  membrane preparat ions.,  In 
order to determine whether the i n h i b i t o r y  e f f e c t  o f  AVT on gonadotropin- 
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Effect of increasing concentrations of []2sI]-hCG on hormone binding 
to par t ia l ly  purified luteal cell plasma membrane preparations in 
the presence or absence of preinjection of AVT. Varying concentra- 
tions of [1251]-hCG were incubated for 90 minutes with the membrane 
preparations. The results indicate specific binding. All assays 
were carried out in t r ip l icate.  
Data from Figure 3 plotted according to Klotz (13). 
induced ovarian steroidogenesis resulted from changes in the binding proper- 
t ies of the gonadotropin receptors, the binding k inet ics in p a r t i a l l y  pur i f ied  
membrane preparations of luteal  ce l ls  were determined with and without pre- 
treatment with AVT. Figure 3 shows the e f fec t  of increasing concentrations Qf 
[1251]-hCG on the binding of  hormone to luteal  cel l  membranes prepared from 
both groups. There was no dif ference in the binding kinet ics between mem- 
branes prepared from the control and AVT treated animals. Equil ibrium data 
plotted according to Klotz (13) demonstrate a single class of gonadotropin 
binding s i tes  with an equi l ibr ium dissociat ion constant (Kd) of 2,66xlO~1°M 
(see inset in Fig. 3). The value for the K d is consistent with previously 
reported f igures (9). AVT treatment did not a l t e r  e i ther  the K d or the number 
of gonadotropin binding s i tes .  
The data presented in th is  study demonstrate that AVT has s ign i f i can t  
i nh ib i t o r y  ef fects d i r e c t l y  on ovarian steroidogenesis. Progesterone produc- 
t ion is diminished fol lowing AVT pretreatment when stimulated with e i ther  hCG 
or the cAMP analogue. In addi t ion,  AVT pretreatment produced no e f fec t  in the 
a b i l i t y  of the membrane preparation to bind 1251-hCG. This suggests that the 
s i te  of i nh ib i t i on  of  ovarian steroidogenesis by AVT is d is ta l  to gonadotropin 
receptor in teract ion and cyc l ic  AMP formation, but rather at a s i te  a f te r  
cyc l ic  AMP formation. Whereas the s i te  and mechanism of the antigonadotropic 
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actions of AVT had not been ident i f ied,  these new findings suggest that one 
of the sites of the antigonadotropic action of AVT is at the ovarian level by 
inh ib i t ing gonadotropin stimulated steroidogenesis. 
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